LBSCX
Price
$35.66
Change
+$0.43 (+1.22%)
Updated
Nov 25 closing price
Net Assets
44.88B
VIVIX
Price
$73.34
Change
+$0.89 (+1.23%)
Updated
Nov 25 closing price
Net Assets
207.95B
Interact to see
Advertisement

LBSCX vs VIVIX

Header iconLBSCX vs VIVIX Comparison
Open Charts LBSCX vs VIVIXBanner chart's image
Columbia Dividend Income C
Price$35.66
Change+$0.43 (+1.22%)
VolumeN/A
Net Assets44.88B
Vanguard Value Index I
Price$73.34
Change+$0.89 (+1.23%)
VolumeN/A
Net Assets207.95B
LBSCX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
LBSCX vs. VIVIX commentary
Nov 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LBSCX is a Buy and VIVIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 208B vs. LBSCX (44.9B). VIVIX pays higher dividends than LBSCX: VIVIX (2.10) vs LBSCX (0.72). LBSCX was incepted earlier than VIVIX: LBSCX (23 years) vs VIVIX (27 years). LBSCX (1.65) is less costly to investors than VIVIX (0.04). LBSCX is a more actively managed with annual turnover of: 16.00 vs. VIVIX (9.00). LBSCX has a lower initial minimum investment than VIVIX: LBSCX (2000) vs VIVIX (5000000). LBSCX annual gain was more profitable for investors over the last year : 3.55 vs. VIVIX (2.61). VIVIX return over 5 years is better than : 59.25 vs. LBSCX (51.58).
LBSCXVIVIXLBSCX / VIVIX
Total Expense Ratio1.650.044,125%
Annual Report Gross Expense Ratio1.650.044,125%
Fund Existence23 years27 years-
Gain YTD13.0149.808133%
Front LoadN/AN/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets44.9B208B22%
Annual Yield % from dividends0.722.1034%
Returns for 1 year3.552.61136%
Returns for 3 years25.3228.3089%
Returns for 5 years51.5859.2587%
Returns for 10 years105.54123.8085%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JFU4.530.33
+7.86%
9F
ATMVU7.750.33
+4.45%
AlphaVest Acquisition Corp
CORT80.282.57
+3.31%
Corcept Therapeutics
CSIQ25.020.09
+0.36%
Canadian Solar
NATR20.41-0.48
-2.30%
Nature's Sunshine Products